Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Provider and Public Health Input for Vaccine Policy Decisions, Potential Extramural Project (PEP), 2007-R-04, 15697 [E7-6010]

Download as PDF Federal Register / Vol. 72, No. 62 / Monday, April 2, 2007 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Interagency Committee on Smoking and Health: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the charter for the Interagency Committee on Smoking and Health (ICSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services, has been renewed for a 2-year period through March 20, 2009. For further information, contact Dana Shelton, Executive Secretary, Interagency Committee on Smoking and Health, Centers for Disease Control Prevention, of the Department of Health and Human Services, CDC, 4770 Buford Highway, NE., M/S K–50, Atlanta, Georgia 30341–3717, telephone 770– 488–5709 or fax 770–488–5767. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention hsrobinson on PROD1PC76 with NOTICES Advisory Council for the Elimination of Tuberculosis: Notice of Charter Renewal. This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Advisory Council for the Elimination of Tuberculosis, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through March 15, 2009. For information, contact Kenneth Castro, M.D., Executive Secretary, Advisory Council for the Elimination of Tuberculosis, Centers for Disease 18:39 Mar 30, 2007 Jkt 211001 Dated: March 26, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. E7–6016 Filed 3–30–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Peer Review of Division of HIV/AIDS Prevention Intramural International Biomedical Interventional Research in Thailand, Kenya, Botswana and Cameroon In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Dated: March 26, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. E7–6020 Filed 3–30–07; 8:45 am] VerDate Aug<31>2005 Control and Prevention, Department of Health and Human Services, 1600 Clifton Road, NE., Mailstop E10, Atlanta, Georgia 30333, telephone 404/ 639–8000 or fax 404/639–8604. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Times and Dates: 8 a.m.–5 p.m., May 2, 2007 (Closed) 8 a.m.–5 p.m., May 3, 2007 (Closed). Place: Corporate Square, 9 Corporate Boulevard, Suite 100, Atlanta, GA 30329, telephone 404–679–7900. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of the ‘‘Division of HIV/AIDS Prevention Intramural International Biomedical Interventional Research in Thailand, Kenya, Botswana and Cameroon.’’ Contact Person for More Information: Elise M. Beltrami, M.D., M.P.H., Designated Federal Official, National Center for Preparedness, Detection and Control of Infectious Diseases, Division of Healthcare Quality Promotion, CDC, 1600 Clifton Road N.E., Mailstop A–31, Atlanta, GA 30333, Telephone 404–639–4271. The Director, Management Analysis and Services Office, has been delegated the PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 15697 authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 26, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–6009 Filed 3–30–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Provider and Public Health Input for Vaccine Policy Decisions, Potential Extramural Project (PEP), 2007–R–04 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12 p.m.–4 p.m., May 8, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to PEP 2007–R–04, ‘‘Provider and Public Health Input for Vaccine Policy Decisions.’’ Contact Person for More Information: Christine J. Morrison, PhD Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road NE, Mailstop D–72, Atlanta, GA 30333, Telephone (404)639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 26, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–6010 Filed 3–30–07; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\02APN1.SGM 02APN1

Agencies

[Federal Register Volume 72, Number 62 (Monday, April 2, 2007)]
[Notices]
[Page 15697]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6010]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Provider and Public Health Input for Vaccine 
Policy Decisions, Potential Extramural Project (PEP), 2007-R-04

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 12 p.m.-4 p.m., May 8, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
PEP 2007-R-04, ``Provider and Public Health Input for Vaccine Policy 
Decisions.''
    Contact Person for More Information: Christine J. Morrison, PhD 
Scientific Review Administrator, Office of the Chief Science 
Officer, CDC, 1600 Clifton Road NE, Mailstop D-72, Atlanta, GA 
30333, Telephone (404)639-3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-6010 Filed 3-30-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.